1 September 2012
The Royal Liverpool University and Broadgreen Hospitals NHS Trust (RLBUHT) has entered into a partnership with Impact Science to create and manage a framework for the Trust’s Intellectual Property.
The Royal Liverpool University Hospital is the largest hospital within the Trust, providing emergency, general and specialist treatment to patients, with more than 700 beds. The Hospital’s research and development portfolio is one of the largest portfolios of clinical research in the North West of England with over 400 clinical research projects covering many disease areas including cancer, gastroenterology, oral health, stroke, ophthalmology, infection and pharmacology.
The addition of capabilities to protect and manage the IP associated with this valuable research activity is a logical progression in the Trusts plans to grow its portfolio of innovative activities.
Under this new partnership, the Impact Science Team is evaluating the Trust’s current IP portfolio and implementing practical systems to both manage the current portfolio and uncover new IP owned by the Trust. Through this arrangement staff involved in research, development and innovation will have access to specialist support from the Impact Science Team, including guidance and training on IP issues, and support for commercialising inventions and innovations.
Jules West, Operational Director of Research Development and Innovation, said: “We are delighted to be working with Impact Science. They are helping us to really focus on commercialisation and intellectual property, which we haven’t been able to do effectively before. This specialist support is invaluable and will help us to grow our portfolio.”
Rhys Roberts of Impact Science said “we are very pleased to be working with RLUBHT, and recognise the huge potential of its clinical research portfolio to generate and add value to IP”.
For further information, contact Dr Rhys Roberts on +44 151 795 4100.